Frank, Rimerman Advisors LLC Novo Nordisk A S Transaction History
Frank, Rimerman Advisors LLC
- $1.4 Billion
- Q3 2024
A detailed history of Frank, Rimerman Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 43,058 shares of NVO stock, worth $3.76 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
43,058
Previous 43,015
0.1%
Holding current value
$3.76 Million
Previous $6.14 Million
16.5%
% of portfolio
0.37%
Previous 0.44%
Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,957Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.76 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.26 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.25 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.16 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.07 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $197B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...